Table 4.

Number of cases with elevated mean CK

	Infliximab		Vedolizumab
	CD (Nf = 31; Nm = 36)	UC (Nf = 17; Nm = 15)	CD (Nf = 10; Nm = 5)	UC (Nf = 6; Nm = 1)
CK
Female mean >157 U/L, n (%)	4 (12.9)	1 (5.9)	2 (20)	0 (0)
CK
Male mean >200 U/L, n (%)	5 (13.9)	2 (13.3)	1 (20)	1 (100)

CK, creatine kinase; CD, Crohn's disease; UC, ulcerative colitis.